You just finished a question on fatty acid synthesis, felt good about the mechanism… and then the explanations slapped you with five different enzymes, two cellular compartments, and a random mention of ethanol. This post is how to turn that chaos into points: we’ll walk through a classic clinical vignette, lock in the correct answer, and then treat every distractor like it could show up as the next question.
Tag: Biochemistry > Lipid Metabolism
The Vignette (Q-bank style)
A 52-year-old man with obesity and type 2 diabetes presents for routine follow-up. He recently stopped drinking alcohol and has been trying to “eat healthier,” but he still has elevated triglycerides. Labs show:
- Fasting glucose: elevated
- Triglycerides: elevated
- AST/ALT: mildly elevated
- Physical exam: central adiposity
His physician explains that in the fed state, excess carbohydrate can be converted into fatty acids in the liver and then packaged into VLDL.
Which of the following is the rate-limiting step in fatty acid synthesis?
A. Acetyl-CoA malonyl-CoA
B. Citrate transport from mitochondria to cytosol
C. Malonyl-CoA inhibition of carnitine palmitoyltransferase I (CPT I)
D. Palmitate palmitoyl-CoA
E. -oxidation of fatty acids in the mitochondrial matrix
Step 1: Identify the Core Concept
This is testing de novo fatty acid synthesis (mostly in liver, also adipose, lactating mammary gland), which is upregulated in the fed state under insulin.
One-sentence pathway map
Excess glucose acetyl-CoA (mitochondria) citrate shuttle to cytosol acetyl-CoA carboxylase makes malonyl-CoA fatty acid synthase builds palmitate.
Correct Answer: A. Acetyl-CoA malonyl-CoA
Why it’s correct (high-yield)
Acetyl-CoA carboxylase (ACC) catalyzes the rate-limiting step of fatty acid synthesis:
Key facts you’re expected to know:
- Enzyme: Acetyl-CoA carboxylase (ACC)
- Cofactor: Biotin (B7) (carries CO)
- Location: Cytosol
- Regulation (classic USMLE):
- Activated by: Insulin, citrate (signals abundant building blocks)
- Inhibited by: Glucagon/epinephrine (via phosphorylation), AMPK, and palmitoyl-CoA (long-chain FA feedback)
The “integration” point that shows up all the time
Malonyl-CoA inhibits CPT I, preventing simultaneous synthesis and breakdown of fatty acids.
Fast Framework: Fed vs Fasting (What the vignette is really hinting at)
| State | Dominant hormone | What liver does with acetyl-CoA | FA synthesis? | -oxidation? |
|---|---|---|---|---|
| Fed | Insulin | Export as citrate to cytosol | Up | Down |
| Fasting | Glucagon | Ketogenesis + TCA limitations | Down | Up |
Now the Money: Why Each Distractor Is Wrong (and what it’s trying to teach)
B. Citrate transport from mitochondria to cytosol
Why it’s tempting: You do need citrate export because acetyl-CoA can’t cross the inner mitochondrial membrane.
Why it’s wrong: It’s important, but it’s not the rate-limiting step. The rate-limiter is ACC.
High-yield add-on: citrate shuttle
- In mitochondria: acetyl-CoA + oxaloacetate citrate
- Citrate crosses to cytosol
- ATP-citrate lyase regenerates cytosolic acetyl-CoA
Board-style clue: If the question asks rate-limiting enzyme, think ACC. If it asks how acetyl-CoA gets to cytosol, think citrate shuttle.
C. Malonyl-CoA inhibition of CPT I
Why it’s tempting: This is a famous regulatory step.
Why it’s wrong: This is a key regulatory linkage between synthesis and oxidation, but it’s not a step in fatty acid synthesis and not the rate-limiting reaction.
High-yield takeaways
- CPT I is for fatty acid oxidation (mitochondrial entry of long-chain fatty acyl-CoA).
- Malonyl-CoA rises during FA synthesis and blocks CPT I, preventing a futile cycle.
USMLE pearl: If malonyl-CoA is high, -oxidation is suppressed.
D. Palmitate palmitoyl-CoA
Why it’s tempting: “Activation” sounds like it could be rate-limiting.
Why it’s wrong: Converting palmitate to palmitoyl-CoA is not the controlling step of de novo synthesis. Palmitate is the end product of fatty acid synthase.
What it’s actually about
- Fatty acids are “activated” to fatty acyl-CoA for transport, oxidation, or lipid synthesis
- But the key testable bottleneck for building fatty acids from scratch is still ACC
Another classic: Fatty acid synthase typically produces palmitate (16:0). Further elongation/desaturation happens in the smooth ER.
E. -oxidation of fatty acids in the mitochondrial matrix
Why it’s tempting: It’s a central lipid metabolism pathway and often paired with synthesis questions.
Why it’s wrong: -oxidation is the catabolic pathway. The vignette is about the fed state converting carbs into fatty acids (anabolic).
High-yield contrast
- FA synthesis: cytosol, uses NADPH
- -oxidation: mitochondria (very long chains start in peroxisomes), produces FADH, NADH, and acetyl-CoA
High-Yield “Don’t Miss” Facts (USMLE favorites)
1) Fatty acid synthesis uses NADPH
Main sources of NADPH:
- Pentose phosphate pathway (HMP shunt)
- Malic enzyme: malate pyruvate + NADPH (often coupled to citrate shuttle)
2) Location matters
- Synthesis: cytosol (ACC + fatty acid synthase)
- Oxidation: mitochondria (CPT system), peroxisomes for very-long-chain FA
3) Biotin deficiency hits carboxylases
Biotin (B7) is a cofactor for:
- Acetyl-CoA carboxylase (FA synthesis)
- Pyruvate carboxylase (gluconeogenesis/anaplerosis)
- Propionyl-CoA carboxylase (odd-chain FA, certain AAs)
4) Insulin vs glucagon logic
- Insulin dephosphorylates/activates ACC ↑ malonyl-CoA ↓ CPT I activity ↓ oxidation
- Glucagon/epi phosphorylate/inhibit ACC ↓ malonyl-CoA ↑ CPT I activity ↑ oxidation
What to Say to Yourself on Test Day (30-second script)
- “Fed state, making fat in liver = fatty acid synthesis.”
- “Rate-limiting step = ACC: acetyl-CoA to malonyl-CoA, needs biotin.”
- “Malonyl-CoA blocks CPT I to stop oxidation while synthesizing.”
- “Synthesis is cytosolic and uses NADPH.”
Quick Recap Table: Enzyme/Concept Matching
| Concept | Answer choice vibes | What it actually tests |
|---|---|---|
| Rate-limiting step of FA synthesis | A | ACC, biotin, malonyl-CoA |
| Moving acetyl-CoA to cytosol | B | Citrate shuttle, ATP-citrate lyase |
| Preventing synthesis + oxidation simultaneously | C | Malonyl-CoA inhibits CPT I |
| Using/storing fatty acids | D | FA activation to acyl-CoA; not rate-limiting synthesis |
| Breaking down fatty acids | E | -oxidation (mitochondria/peroxisomes) |